ARMISTICE CAPITAL LLC 13D and 13G filings for Agios Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 3:44 pm Sale | 2024-09-30 | 13G | Agios Pharmaceuticals, Inc. AGIO | ARMISTICE CAPITAL LLC | 2,207,070 3.880% | -1,316,930 (-37.37%) | Filing |
| 2024-02-14 2:21 pm Purchase | 2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | ARMISTICE CAPITAL LLC | 3,524,000 6.310% | 774,000 (+28.15%) | Filing |
| 2023-02-14 11:54 am Purchase | 2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | ARMISTICE CAPITAL LLC | 2,750,000 5.010% | 2,750,000 (New Position) | Filing |